| Article

Refreshments will be served.

*This session is not certified for credit.

| Article

| Article

The prevalence of back pain continues in spite of the many treatments available, without any single treatment being a panacea. In routine clinical practice there has been a tendency of clinical examinations to become more cursory, largely influenced by increasing demands of time and arguably an...

| Article

Lunch will be served.

Sponsored by AstraZeneca-Daiichi Sankyo, Inc.

*This session is not certified for credit.

| Article

| Article

| Article

After last year’s talk about the CDC Guideline, a lot has begun to change, begrudgingly. While this is encouraging, there are still both medical and nonmedical people who don’t want to see any changes in the weak to very weak (evidenced-based medicine) CDC Guideline, which has gone far from what it...

| Article

Nonopioid analgesics are considered first-line therapy for most chronic pain syndromes. A strong recall of these agents’ safety and efficacy profiles is paramount for today’s pain practitioner. This course will provide an in-depth look at each of the agents within these drug classes, their potential...

| Article

| Article

Breakfast will be served.

*This session is not certified for credit.

Subscribe to PAINWeekEnd

Sign-Up